Small Caps

Everything about small-cap stocks

Pharmaceutical manufacturer Liquidia announced that it has settled all legal disputes with its competitor, United Therapeutics / Photo: Liquidia
Small Caps·
Shares of biotech company Liquidia soared 27%. It has settled a patent dispute with a competitor
Since the beginning of the year, shares of the photo-editing app Meitu have fallen 50% / Photo: TREKPix / Shutterstock.com
Small Caps·
The AI market is said to be overheated. Which stocks remain undervalued?
Iambic is developing anticancer drugs using its AI platform / Photo: Iambic
Small Caps·
Iambic IPO: Trading Begins in the Biotech Stock, Backed by Nvidia and Cathie Wood
The Russell 2000 has fallen more than 11% since mid-August / Photo: X / NYSE
Small Caps·
+1
·
The index of high-risk stocks has entered a correction: The Russell 2000 has fallen 11% from its peak
Small Caps·
China, TikTok, and Gen Z: CNBC analyst sees opportunity in Crocs
Small Caps·
Bumble has its best day ever as dating-app company in 'advanced' talks to go private
Small Caps·
Russell 2000 nears correction, down ~9% from August peak. What should investors do?
Small Caps·
Oppenheimer upgrades Fastly to ‘outperform’ ahead of 3Q earnings and GTA VI launch
Freedom has started its coverage with a buy rating / Photo: Once Upon a Farm
Small Caps·
Freedom initiates on Jennifer Garner's Once Upon a Farm at TP offering 50% upside
Webull’s China-based operations put U.S.investors and their data at risk, the U.S. House Select Committee on China has concluded / Photo: Facebook / Webull
Small Caps·
Small caps last week: Webull risks, Levi’s outlook, Vaxcyte trial success
Pacira’s EXPAREL treats acute postsurgical pain / Photo: Unsplash/Roberto Sorin
Small Caps·
Pacira soars 44% as Viatris agrees to buy biotech to boost non-opioid pain portfolio
Small Caps·
AI can halve drug development time. Here are 3 smaller AI biotechs Cathie Wood likes.
Small Caps·
+1
·
TRex Bio IPO: LLY-backed biotech focused on autoimmune, inflammatory diseases debuts
Small Caps·
Levi's slides as baggy-jeans bet misses mark in 3Q; analysts see nearly 40% upside
Small Caps·
Chipmaker Wolfspeed soars on $1.5 bln U.S. loan commitment after bankruptcy exit